|Bid||236.55 x 800|
|Ask||236.87 x 800|
|Day's range||235.05 - 237.55|
|52-week range||179.23 - 252.67|
|Beta (5Y monthly)||0.99|
|PE ratio (TTM)||47.86|
|Earnings date||26 Oct 2021 - 01 Nov 2021|
|Forward dividend & yield||1.28 (0.53%)|
|Ex-dividend date||12 Aug 2021|
|1y target est||268.97|
Benchmarks closed in the positive territory on Tuesday, as investors ignored the rise in new cases of the delta variant, and instead focused more on the upbeat second-quarter earnings results.
Three stocks that fall into that bucket and that have outperformed the market over the past five years are Abbott Laboratories (NYSE: ABT), Adobe (NASDAQ: ADBE), and Visa (NYSE: V). One of the reasons to be bullish on Abbott Laboratories is the diversity of its business.
Square's (SQ) is acquisition of Australian buy now, pay later (BNPL) company Afterpay for $29 billion is an indication of a rapidly growing industry, according to one rival firm's chief executive.